The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus
Kidney Int., Available online 1 November 2022 | https://doi.org/10.1016/j.kint.2022.09.031
Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
Diabetologia, Published: 21 December 2021 | https://doi.org/10.1007/s00125-021-05627-9
